Products / Services

At present, the company has established extensive, in-depth and long-term cooperative relationships with many hospitals, and researches on multiple cancers such as lung cancer, colorectal cancer and gynecological tumors. The research direction covers the screening of early tumor markers and the prognosis. evaluation, tumor heterogeneity molecular classification and other fields, and

achieved fruitful results.

Genecast Focus

Genecast Focus is our NGS-based test for multi-gene mutation detection and determination of MSI status of 23 cancers, including breast cancer, colorectal cancer, gastric cancer, gastrointestinal melanoma, head and neck squamous cancer, lung cancer, melanoma, ovarian cancer, thyroid cancer and multiple types of solid tumors. 


Genecast Focus detects SNVs, Indels, fusions and CNVs in 122 genes, and determines MSI status in genomic DNA extracted from FFPE tissue samples and liquid biopsy samples. 


It combines genetic testing by sequencing the DNA of FFPE tissue samples and liquid biopsy samples with analysis against a proprietary database and algorithm, to determine gene mutations and provides the most effective targeted therapy or chemotherapy recommendation, as well as auxiliary support for immunotherapy for the patient.